Search

everythinglearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Pdgfα signaling helps maintain fat cells in the skin and is important for hair growth, wound healing, and fighting infections.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Piperonylic acid may help hair growth and treat hair loss.

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.